Detalhe da pesquisa
1.
The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial.
Clin Gastroenterol Hepatol
; 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237696
2.
Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.
Gastroenterology
; 160(1): 76-87.e4, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693185
3.
Elevated plasma levels of CXCL16 in severe COVID-19 patients.
Cytokine
; 152: 155810, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121493
4.
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon.
J Sleep Res
; 31(1): e13430, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152055
5.
Tasimelteon safely and effectively improves sleep in Smith-Magenis syndrome: a double-blind randomized trial followed by an open-label extension.
Genet Med
; 23(12): 2426-2432, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34316024
6.
Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'.
Cytokine
; 148: 155662, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34353696
7.
Corrigendum to "Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients" [Cytokine 148 (2021) 155662].
Cytokine
; 149: 155752, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756793
8.
Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
Lancet
; 386(10005): 1754-64, 2015 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26466871
9.
Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis.
J Am Acad Dermatol
; 85(6): 1638-1640, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421484
10.
Screening effects of HCN channel blockers on sleep/wake behavior in zebrafish.
Front Neurosci
; 18: 1375484, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38567282
11.
Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study.
J Clin Psychiatry
; 85(1)2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236020
12.
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness.
PLoS One
; 18(1): e0280058, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602998
13.
Enrichment of Patients With Ehlers Danlos Syndrome in Idiopathic Gastroparesis-A Gene Set Enrichment Analysis.
Clin Transl Gastroenterol
; 14(3): e00521, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000988
14.
Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.
Front Neurosci
; 17: 1287514, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033548
15.
Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.
Front Neurosci
; 17: 1344915, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260023
16.
Case report: A novel missense variant in melanopsin associates with delayed sleep phenotype: Whole genome sequencing study.
Front Genet
; 13: 896192, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36246649
17.
Enrichment of Motilin Receptor Loss-of-Function Variants in Gastroparesis.
Clin Transl Gastroenterol
; 13(4): e00474, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297797
18.
Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection.
Virology
; 572: 64-71, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598394
19.
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial.
Front Neurol
; 13: 901467, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36188367
20.
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.
J Glob Antimicrob Resist
; 26: 239-240, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273592